Session: OS3-025
Targeted drug delivery and Nanocarriers - Nanomedecine for cancer diagnosis & therapy

Teresa Simon-Yarza (Institut Lavoisier, UMR8180 CNRS/Université de Versailles St-Quentin en Yvelines), Monica Gimenez-marques (Institut Lavoisier, UMR8180 CNRS/Université de Versailles St-Quentin en Yvelines), Rhizlaine Mrimi (Institut Lavoisier, UMR8180 CNRS/Université de Versailles St-Quentin en Yvelines), Angelika Mielcarek (Ecole Normale Superieure), Ruxandra Gref (Institut Galien, UMR8612 CNRS, Université Paris-Sud), Patricia Horcajada (Institut Lavoisier, UMR8180 CNRS/Université de Versailles St-Quentin en Yvelines), christian serre (Institut Lavoisier, UMR8180 CNRS/Université de Versailles St-Quentin en Yvelines), Patrick Couvreur (Institut Galien, UMR8612 CNRS, Université Paris-Sud)

David Plackett (Faculty of Pharmaceutical Sciences, University of British Columbia), Clement Mugabe (The Centre for Drug Research and Development (CDRD)), Shujun Lin (The Centre for High-Throughput Phenogenomics (CHTP), Faculty of Dentistry, University of British Columbia), Guobin Sun (The Centre for High-Throughput Phenogenomics (CHTP), Faculty of Dentistry, University of British Columbia), Nancy Ford (The Centre for High-Throughput Phenogenomics (CHTP), Faculty of Dentistry, University of British Columbia), Richard Liggins (The Centre for Drug Research and Development (CDRD)), Helen Burt (Faculty of Pharmaceutical Sciences, University of British Columbia)

MASAKI OTAGIRI (Faculty of Pharm Sci., Sojo University), Yu Ishima (Faculty of Pharm Sci , Kumamoto University), Toru Maruyama (Faculty of Pharm Sci , Kumamoto University)

erika porcel (ISMO Université Paris Sud/CNRS), Marta Bolsa (ISMO Université Paris Sud/CNRS), Daniela Salado (ISMO Université Paris Sud/CNRS), Lenka Stefancikova (ISMO Université Paris Sud/CNRS), Vladimir Ivosev (ISMO Université Paris Sud/CNRS), Sandrine Lacombe (ISMO Université Paris Sud/CNRS)